These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30905723)

  • 1. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness.
    Basu S; Serna-Ojeda JC; Senthil S; Pappuru RR; Bagga B; Sangwan V
    Am J Ophthalmol; 2019 Sep; 205():175-183. PubMed ID: 30905723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of the Boston type 1 and the Aurolab keratoprosthesis in eyes with limbal stem cell deficiency.
    Shanbhag SS; Senthil S; Mohamed A; Basu S
    Br J Ophthalmol; 2021 Apr; 105(4):473-478. PubMed ID: 32554443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glaucoma Evaluation and Management in Eyes With Boston Type 1 and Aurolab Keratoprostheses in an Indian Cohort.
    Senthil S; Mohamed A; Shanbhag SS; Durgam SS; Bagga B; Sangwan VS; Basu S
    Cornea; 2022 May; 41(5):552-561. PubMed ID: 35383615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
    Robert MC; Biernacki K; Harissi-Dagher M
    Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review and Meta-Analysis of the Medium- and Long-Term Outcomes of the Boston Type 1 Keratoprosthesis.
    Priddy J; Bardan AS; Tawfik HS; Liu C
    Cornea; 2019 Nov; 38(11):1465-1473. PubMed ID: 31403526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and complications of Boston keratoprosthesis type I implantation in unilateral versus bilateral corneal blindness.
    Touma S; Harissi-Dagher M
    Can J Ophthalmol; 2021 Apr; 56(2):130-136. PubMed ID: 33002416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of bilateral sequential implantation of the Boston keratoprosthesis type 1.
    Vaillancourt L; Papanagnu E; Elfekhfakh M; Fadous R; Harissi-Dagher M
    Can J Ophthalmol; 2017 Feb; 52(1):80-84. PubMed ID: 28237154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
    Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
    Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratoprosthesis: Current global scenario and a broad Indian perspective.
    Iyer G; Srinivasan B; Agarwal S; Talele D; Rishi E; Rishi P; Krishnamurthy S; Vijaya L; Subramanian N; Somasundaram S
    Indian J Ophthalmol; 2018 May; 66(5):620-629. PubMed ID: 29676302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
    Pujari S; Siddique SS; Dohlman CH; Chodosh J
    Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Outcomes of a Novel Keratoprosthesis: Addressing Unmet Needs in End-Stage Cicatricial Corneal Blindness.
    Bakshi SK; Graney J; Paschalis EI; Agarwal S; Basu S; Iyer G; Liu C; Srinivasan B; Chodosh J
    Cornea; 2020 Apr; 39(4):484-490. PubMed ID: 31724985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
    Aravena C; Bozkurt TK; Yu F; Aldave AJ
    Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
    Geoffrion D; Harissi-Dagher M
    Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boston Keratoprosthesis type 1 (KPro) without contact lens wearing in end-stage corneal disease: The APEC experience.
    De Wit-Carter G; Hernández-Chavarría C; Navarro-Naranjo PI; Manzanillo-Rosario C; Navarro-Saucedo R; García-Albisua AM; Hernandez-Quintela E; Cabrera-Martínez E; Ordoñez-Ranz G; Sanchez-Huerta V
    Eur J Ophthalmol; 2024 Jul; 34(4):1063-1070. PubMed ID: 38099653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glaucoma associated with Boston type I keratoprosthesis.
    Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
    Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
    Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
    Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia.
    Shah KJ; Cheung AY; Holland EJ
    Cornea; 2018 Jan; 37(1):11-14. PubMed ID: 28990998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratoprostheses in silicone oil-filled eyes: long-term outcomes.
    Iyer G; Srinivasan B; Agarwal S; Pattanaik R; Rishi E; Rishi P; Shanmugasundaram S; Natarajan V
    Br J Ophthalmol; 2019 Jun; 103(6):781-788. PubMed ID: 30021817
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.